Evaluation of Natural Killer Activated Receptor NKG2D, Inhibitory Receptor KIR2DL1 and Soluble Ligand MICA in Iraqi Patients of Acute Myeloid Leukemia. Journal of Pharmaceutical Negative Results 2022, 13, 148-155. https://doi.org/10.47750/pnr.2022.13.S05.21.